rimantadine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyauchi, S | 1 |
| Sanders, PD | 1 |
| Guram, K | 1 |
| Kim, SS | 1 |
| Paolini, F | 1 |
| Venuti, A | 1 |
| Cohen, EEW | 1 |
| Gutkind, JS | 1 |
| Califano, JA | 1 |
| Sharabi, AB | 1 |
1 other study available for rimantadine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
Topics: Adolescent; Adult; Aged; Animals; Antigen Presentation; Antineoplastic Agents, Immunological; Antine | 2020 |